APGE vs FDX · $2.34B cap vs P/E 18, rev $94.72B
Apogee Therapeutics, Inc. Common Stock (APGE) versus FedEx Corporation (FDX) — a side-by-side from cached financials, not a winner call.
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
FedEx Corporation (FDX) is a integrated freight & logistics company listed on US.
APGE does not have a complete income-statement cache yet.
Latest reported FDX revenue for 2026-05-31 was $94.72B. Net income was $4.43B. Revenue was up 7.7% from 2025-05-31 to 2026-05-31. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
APGE currently screens at market cap $2.34B. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
Not investment advice. Open the APGE and FDX stock pages for the full models.
Not investment advice.